Frankfurt - Delayed Quote EUR
Amgen Inc. (AMG.F)
245.00
+1.00
+(0.41%)
At close: April 24 at 2:32:46 PM GMT+2
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 1.17M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| BRADWAY ROBERT A Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 3, 2025 |
| GRAHAM JONATHAN P General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 3, 2025 |
| BUSCH MATTHEW C. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 3, 2025 |
| SANTOS ESTEBAN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 3, 2025 |
| GRIFFITH PETER H. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 3, 2025 |
| GRYGIEL NANCY A Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 3, 2025 |
| GORDON MURDO Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 3, 2025 |
| REESE DAVID M. Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 3, 2025 |
| KHOSLA RACHNA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 3, 2025 |
| MILLER DEREK Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 3, 2025 |
| REESE DAVID M. Chief Technology Officer | Sale at price 293.22 - 304.44 per share. | Direct | 10,233,748 | Feb 21, 2025 |
| SANTOS ESTEBAN Officer | Conversion of Exercise of derivative security at price 156.35 per share. | Direct | 1,361,965 | Feb 19, 2025 |
| REESE DAVID M. Chief Technology Officer | Conversion of Exercise of derivative security at price 156.35 per share. | Direct | 1,361,965 | Feb 19, 2025 |
| MILLER DEREK Officer | Conversion of Exercise of derivative security at price 156.35 per share. | Direct | 238,277 | Feb 19, 2025 |
| MILLER DEREK Officer | Sale at price 292.56 - 293.74 per share. | Direct | 593,934 | Feb 19, 2025 |
| SANTOS ESTEBAN Officer | Sale at price 292.84 per share. | Direct | 2,550,903 | Feb 19, 2025 |
| GORDON MURDO Officer | Sale at price 294.79 per share. | Direct | 2,585,644 | Feb 11, 2025 |
| GRAHAM JONATHAN P General Counsel | Conversion of Exercise of derivative security at price 156.35 per share. | Direct | 3,915,786 | Feb 7, 2025 |
| GRAHAM JONATHAN P General Counsel | Sale at price 293.12 per share. | Direct | 7,341,123 | Feb 7, 2025 |
| GRYGIEL NANCY A Officer | Sale at price 304.47 per share. | Direct | 483,808 | Feb 5, 2025 |
| GRAHAM JONATHAN P General Counsel | Stock Gift at price 0.00 per share. | Direct | 0 | Dec 5, 2024 |
| BRADWAY ROBERT A Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Dec 2, 2024 |
| ISHRAK OMAR SYED Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 4, 2024 |
| DRAKE MICHAEL V Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 4, 2024 |
| HOLLEY CHARLES M JR Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 4, 2024 |
| ISHRAK OMAR SYED Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 9, 2024 |
| DRAKE MICHAEL V Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 9, 2024 |
| HOLLEY CHARLES M JR Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 9, 2024 |
| JACKS TYLER Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
| ISHRAK OMAR SYED Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
| GARLAND GREGORY C. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
| DRAKE MICHAEL V Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
| KLOTMAN MARY E Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
| AUSTIN WANDA M Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
| DRUKER BRIAN J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
| MILES AMY E Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
| ECKERT ROBERT ANDREW Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
| KULLMAN ELLEN JAMISON Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
| HOLLEY CHARLES M JR Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
| BRADWAY ROBERT A Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2024 |
| ISHRAK OMAR SYED Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2024 |
| GRAHAM JONATHAN P General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2024 |
| DRAKE MICHAEL V Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2024 |
| BRADNER JAMES E. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2024 |
| BUSCH MATTHEW C. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2024 |
| SANTOS ESTEBAN Officer | Stock Award(Grant) at price 300.30 per share. | Direct | 899,999 | May 7, 2024 |
| GRIFFITH PETER H. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2024 |
| GRYGIEL NANCY A Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2024 |
| GORDON MURDO Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2024 |
| REESE DAVID M. Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2024 |
Related Tickers
IDP.HM Biogen Inc
105.20
+0.91%
0QCV.IL AbbVie Inc.
178.90
+0.85%
GIS.F Gilead Sciences, Inc.
93.51
+0.73%
GLAXF GSK plc
18.46
+6.58%
CUP.F Chugai Pharmaceutical Co., Ltd.
50.40
-0.79%
REC.MI Recordati Industria Chimica e Farmaceutica S.p.A.
49.22
+0.49%
LLY.F Eli Lilly and Company
757.00
+3.88%
NOV.DE Novo Nordisk A/S
54.96
+1.33%
SNY Sanofi
53.54
+0.98%
GSK GSK plc
37.50
+1.27%